Financial Snapshot

Revenue
$331.5M
TTM
Gross Margin
43.96%
TTM
Net Earnings
-$52.69M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
265.97%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$185.4M
Q3 2024
Cash
Q3 2024
P/E
-4.620
Nov 29, 2024 EST
Free Cash Flow
-$11.65M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $315.7M $377.2M $358.0M $308.5M $361.9M $358.1M $249.4M $168.2M $159.0M $112.5M $75.44M $48.58M $30.60M
YoY Change -16.32% 5.37% 16.05% -14.77% 1.07% 43.57% 48.32% 5.76% 41.29% 49.17% 55.31% 58.75%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $315.7M $377.2M $358.0M $308.5M $361.9M $358.1M $249.4M $168.2M $159.0M $112.5M $75.44M $48.58M $30.60M
Cost Of Revenue $189.0M $223.7M $181.5M $170.3M $176.0M $179.5M $128.2M $105.5M $82.75M $57.02M $36.45M $24.63M $15.90M
Gross Profit $126.7M $153.5M $176.5M $138.2M $171.9M $178.6M $121.2M $97.31M $76.26M $55.52M $38.99M $23.95M $14.70M
Gross Profit Margin 40.14% 40.7% 49.3% 44.79% 47.48% 49.87% 48.6% 57.86% 47.96% 49.33% 51.68% 49.3% 48.04%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Selling, General & Admin $182.4M $164.7M $149.7M $137.0M $142.7M $133.7M $88.33M $69.33M $57.03M $42.03M $32.13M $20.86M $14.60M
YoY Change 10.74% 10.0% 9.27% -3.97% 6.71% 51.36% 27.41% 21.58% 35.68% 30.81% 54.04% 42.86%
% of Gross Profit 143.92% 107.26% 84.83% 99.15% 83.02% 74.87% 72.86% 71.25% 74.78% 75.7% 82.4% 87.09% 99.32%
Research & Development $20.84M $21.94M $8.763M $14.10M $9.401M $7.029M $5.313M $5.113M $4.180M $2.977M $2.398M $2.262M $1.800M
YoY Change -5.03% 150.41% -37.85% 49.98% 33.75% 32.3% 3.91% 22.32% 40.41% 24.15% 6.01% 25.67%
% of Gross Profit 16.45% 14.29% 4.97% 10.2% 5.47% 3.94% 4.38% 5.25% 5.48% 5.36% 6.15% 9.45% 12.24%
Depreciation & Amortization $18.15M $23.51M $21.63M $18.58M $13.83M $11.30M $12.30M $13.56M $14.01M $12.08M $8.544M $4.984M $3.200M
YoY Change -22.8% 8.72% 16.4% 34.31% 22.48% -8.19% -9.26% -3.24% 15.99% 41.39% 71.43% 55.75%
% of Gross Profit 14.33% 15.32% 12.26% 13.45% 8.05% 6.32% 10.15% 13.93% 18.37% 21.76% 21.91% 20.81% 21.77%
Operating Expenses $236.1M $238.8M $167.2M $151.1M $152.1M $140.7M $93.65M $74.45M $61.21M $45.01M $34.53M $23.12M $16.50M
YoY Change -1.13% 42.77% 10.68% -0.64% 8.09% 50.23% 25.79% 21.63% 36.0% 30.35% 49.34% 40.12%
Operating Profit -$109.4M -$85.24M $9.240M -$12.92M $19.79M $37.89M $27.59M $22.86M $15.05M $10.51M $4.464M $829.0K -$1.800M
YoY Change 28.32% -1022.54% -171.52% -165.29% -47.78% 37.34% 20.67% 51.91% 43.19% 135.46% 438.48% -146.06%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Interest Expense $6.574M $2.837M $129.0K $900.0K $4.700M $3.300M $800.0K $6.000K $22.00K $449.0K $562.0K $493.0K -$300.0K
YoY Change 131.72% 2099.22% -85.67% -80.85% 42.42% 312.5% 13233.33% -72.73% -95.1% -20.11% 14.0% -264.33%
% of Operating Profit 1.4% 23.75% 8.71% 2.9% 0.03% 0.15% 4.27% 12.59% 59.47%
Other Income/Expense, Net $7.042M $1.975M -$710.0K $500.0K $4.483M $2.563M $2.066M -$139.0K -$324.0K -$459.0K -$616.0K -$247.0K $0.00
YoY Change 256.56% -378.17% -242.0% -88.85% 74.91% 24.06% -1586.33% -57.1% -29.41% -25.49% 149.39%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Pretax Income -$102.3M -$83.27M $8.659M -$5.280M $24.27M $40.46M $29.66M $22.73M $14.73M $10.05M $3.848M $600.0K -$2.000M
YoY Change 22.91% -1061.64% -264.0% -121.75% -40.0% 36.41% 30.5% 54.31% 46.51% 161.23% 541.33% -130.0%
Income Tax $105.0K $504.0K $14.99M $549.0K $3.322M -$11.39M $8.654M $2.206M $3.142M $3.226M -$21.59M $0.00 $0.00
% Of Pretax Income 173.14% 13.69% -28.15% 29.18% 9.71% 21.33% 32.09% -560.99% 0.0%
Net Earnings -$102.4M -$83.77M -$6.333M -$5.829M $20.95M $51.85M $21.00M $20.52M $11.59M $6.826M $25.44M $600.0K -$2.000M
YoY Change 22.3% 1222.79% 8.65% -127.82% -59.59% 146.86% 2.35% 77.12% 69.72% -73.16% 4139.17% -130.0%
Net Earnings / Revenue -32.46% -22.21% -1.77% -1.89% 5.79% 14.48% 8.42% 12.2% 7.29% 6.07% 33.71% 1.24% -6.54%
Basic Earnings Per Share -$4.42 -$3.67 -$0.28 -$0.27 $0.96 $2.44 $1.02 $1.02 $0.60 $0.33 $0.76
Diluted Earnings Per Share -$4.42 -$3.67 -$0.28 -$0.27 $0.94 $2.30 $0.96 $0.97 $0.56 $0.30 $0.68 -$19.97 -$2.857M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Cash & Short-Term Investments $128.5M $187.0M $245.5M $231.2M $209.1M $240.3M $173.9M $113.9M $82.90M $56.80M $13.50M $15.10M $3.900M
YoY Change -31.3% -23.83% 6.19% 10.57% -12.98% 38.18% 52.68% 37.39% 45.95% 320.74% -10.6% 287.18%
Cash & Equivalents $125.5M $187.0M $235.5M $212.0M $198.0M $196.6M $143.0M $92.90M $66.10M $56.80M $13.50M $15.10M $3.900M
Short-Term Investments $2.979M $0.00 $9.989M $19.30M $11.10M $43.70M $31.00M $21.00M $16.80M
Other Short-Term Assets $13.85M $19.19M $26.01M $17.90M $10.20M $7.500M $3.000M $2.100M $1.300M $6.600M $4.700M $500.0K $500.0K
YoY Change -27.84% -26.22% 45.28% 75.49% 36.0% 150.0% 42.86% 61.54% -80.3% 40.43% 840.0% 0.0%
Inventory $21.84M $34.09M $31.87M $24.80M $35.70M $27.10M $18.80M $14.30M $8.600M $7.600M $4.200M $4.100M $1.700M
Prepaid Expenses
Receivables $42.24M $62.73M $24.45M $29.70M $34.30M $37.00M $31.40M $30.80M $19.90M $19.30M $10.20M $7.000M $4.400M
Other Receivables $669.0K $1.626M $1.343M $2.100M $3.000M $2.700M $1.400M $500.0K $2.100M $2.200M $100.0K $0.00 $0.00
Total Short-Term Assets $207.1M $304.6M $329.2M $305.7M $292.2M $314.6M $228.5M $161.5M $114.8M $92.50M $32.80M $26.70M $10.40M
YoY Change -32.03% -7.46% 7.68% 4.62% -7.12% 37.68% 41.49% 40.68% 24.11% 182.01% 22.85% 156.73%
Property, Plant & Equipment $70.65M $64.92M $63.84M $37.10M $25.30M $22.30M $20.10M $25.20M $30.70M $31.90M $29.70M $20.30M $12.80M
YoY Change 8.83% 1.7% 72.07% 46.64% 13.45% 10.95% -20.24% -17.92% -3.76% 7.41% 46.31% 58.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.825M $2.445M $3.363M $17.10M $19.30M $33.00M $19.40M $27.10M $15.60M $15.30M $19.60M $100.0K $100.0K
YoY Change 56.44% -27.3% -80.33% -11.4% -41.52% 70.1% -28.41% 73.72% 1.96% -21.94% 19500.0% 0.0%
Total Long-Term Assets $119.1M $100.4M $160.3M $156.2M $155.1M $61.30M $46.60M $52.50M $46.50M $47.60M $49.60M $20.90M $13.70M
YoY Change 18.66% -37.38% 2.64% 0.71% 153.02% 31.55% -11.24% 12.9% -2.31% -4.03% 137.32% 52.55%
Total Assets $326.2M $405.0M $489.5M $461.9M $447.3M $375.9M $275.1M $214.0M $161.3M $140.1M $82.40M $47.60M $24.10M
YoY Change
Accounts Payable $23.51M $29.07M $10.26M $12.50M $16.40M $13.70M $9.500M $5.700M $7.400M $11.30M $8.800M $6.000M $5.700M
YoY Change -19.14% 183.43% -17.94% -23.78% 19.71% 44.21% 66.67% -22.97% -34.51% 28.41% 46.67% 5.26%
Accrued Expenses $21.35M $19.61M $23.64M $21.20M $11.40M $14.90M $10.70M $8.900M $7.100M $4.100M $2.900M $2.400M
YoY Change 8.92% -17.08% 11.52% 85.96% -23.49% 39.25% 20.22% 25.35% 73.17% 41.38% 20.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $300.0K $300.0K $5.300M $3.900M $2.500M
YoY Change -100.0% 0.0% -94.34% 35.9% 56.0%
Total Short-Term Liabilities $72.50M $65.35M $61.51M $56.70M $50.20M $46.60M $33.90M $22.80M $22.00M $18.70M $18.80M $13.80M $9.100M
YoY Change 10.94% 6.24% 8.49% 12.95% 7.73% 37.46% 48.68% 3.64% 17.65% -0.53% 36.23% 51.65%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $300.0K $5.400M $5.100M $7.100M
YoY Change -100.0% -94.44% 5.88% -28.17%
Other Long-Term Liabilities $40.35M $42.29M $57.77M $55.50M $52.50M $18.70M $13.80M $9.100M $5.300M $2.900M $1.900M $200.0K $300.0K
YoY Change -4.59% -26.81% 4.1% 5.71% 180.75% 35.51% 51.65% 71.7% 82.76% 52.63% 850.0% -33.33%
Total Long-Term Liabilities $40.35M $42.29M $57.77M $55.50M $52.50M $18.70M $13.80M $9.100M $5.300M $3.200M $7.300M $5.300M $7.400M
YoY Change -4.59% -26.81% 4.1% 5.71% 180.75% 35.51% 51.65% 71.7% 65.63% -56.16% 37.74% -28.38%
Total Liabilities $121.4M $107.6M $119.3M $112.2M $102.7M $65.50M $48.00M $32.00M $27.30M $21.90M $26.10M $19.00M $16.60M
YoY Change 12.77% -9.77% 6.32% 9.25% 56.79% 36.46% 50.0% 17.22% 24.66% -16.09% 37.37% 14.46%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Basic Shares Outstanding 23.18M 22.85M 22.49M 21.98M 21.82M 21.27M 20.68M 20.07M 19.40M 16.18M 276.5K 261.3K
Diluted Shares Outstanding 23.18M 22.85M 22.49M 21.98M 22.24M 22.51M 21.90M 21.10M 20.71M 18.04M 2.008M 261.3K
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $243.42 Million

About Inogen Inc

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 834 full-time employees. The company went IPO on 2014-02-14. The firm supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. The company also offers Simeox, which is an airway clearance device.

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: ABBOTT LABORATORIES ARTIVION, INC. Senseonics Holdings, Inc. Axogen, Inc. Cardiovascular Systems Inc Cue Health Inc. Vicarious Surgical Inc. ViewRay, Inc. SI-BONE, Inc. SURMODICS INC